Heterozygous ATM pathogenic variants are known to result in significant breast cancer susceptibility and confer an increased risk for gastric, pancreatic, colorectal, ovarian, and prostate cancers (and susceptibility to breast cancer; MIM #114480) [17]. This evidence concerns the gene ATM and prostate cancer.